FDA Drug Application (072061) for NALIDIXIC ACID by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number072061
Product Number001
FormTABLET;ORAL
Dosage500MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNALIDIXIC ACID
Active IngredientNALIDIXIC ACID

Active IngredientCount
List of drugs with Active Ingredient NALIDIXIC ACID2


Back to FDA Applications sponsored by WATSON LABS